New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
06:41 EDTMDCOThe Medicines Co. price target raised to $37 from $34 at Leerink
Leerink raised its price target for The Medicines Co. after the company announced positive Phase 3 results of the PHOENIX trial of Cangrelor. The firm estimates Cangrelor could address a $200M U.S. market opportunity and reiterates an Outperform rating on the stock.
News For MDCO From The Last 14 Days
Check below for free stories on MDCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
09:59 EDTMDCOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:17 EDTMDCOThe Medicines Co. downgraded to Market Perform from Outperform at Leerink
Subscribe for More Information
April 4, 2014
08:43 EDTMDCOPointState Capital reports 7.3% passive stake in The Medicines Co.
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use